GH
Guardant Health, Inc.
Stock
$177.80+3.05 (+1.75%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$185M | −$185M | −$240M | −$325M | −$309M | −$209M | −$104M | −$47M | −$72M | −$72M | −$37M |
| Capital expenditures | $56M | $48M | $35M | $20M | $77M | $75M | $36M | $19M | $20M | $6.7M | $1.8M |
| Free cash flow | −$241M | −$233M | −$275M | −$345M | −$387M | −$284M | −$140M | −$66M | −$92M | −$79M | −$38M |
| Stock-based compensation | $191M | $166M | $140M | $91M | $95M | $151M | $144M | $17M | $6.9M | $3.7M | $2.0M |
| Buybacks | $0 | $45M | $0 | $0 | — | — | $0 | $0 | $172K | $7.2M | $100K |
| Free cash flow margin | −20.3% | −23.7% | −37.2% | −61.3% | −86.1% | −76.0% | −48.9% | −30.7% | −101.9% | −158.3% | −152.4% |